Research
Hormonal
Insulin resistance is a primary antecedent metabolic abnormality in many patients with NAFLD and NASH, driving fat accumulation and potentially hepatocellular injury.
Managing insulin resistance through lifestyle changes is a key strategy for addressing the root cause of fatty liver disease. This involves weight management, exercise, and dietary adjustments to improve how the body handles insulin.
GoodSupportsHIGH confidence
This model places insulin resistance at the top as an important antecedent metabolic abnormality in many patients.
Why this rating
Based on a consensus model presented at a specialized conference, supported by animal and human mechanistic studies.
Source
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Brent A. Neuschwander‐Tetri et al. · Hepatology · 2003
DOI 10.1053/jhep.2003.50193
narrative_reviewCited 2,149×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →